tiprankstipranks
Day One Biopharmaceuticals, Inc. (DAWN)
:DAWN
US Market

Day One Biopharmaceuticals (DAWN) Income Statement

Compare
325 Followers

Day One Biopharmaceuticals Income Statement

Last quarter (Q4 2024), Day One Biopharmaceuticals's total revenue was $29.21M, an increase of 5115.71% from the same quarter last year. In Q4, Day One Biopharmaceuticals's net income was $-65.71M. See Day One Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 131.16M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 125.88M$ -383.00K$ -531.00K$ -199.00K$ -155.00K
Operating Expenses
$ 343.15M$ 206.06M$ 146.91M$ 72.74M$ 13.78M
Depreciation and Amortization
$ 0.00$ 383.00K$ 531.00K$ 199.00K$ 155.00K
EBITDA
$ -217.27M$ -206.06M$ -141.65M$ -72.56M$ -43.66M
Operating Income
$ -217.27M$ -206.06M$ -146.91M$ -72.74M$ -13.78M
Other Income/Expenses
$ 128.92M$ 17.15M$ 4.73M$ -11.00K$ -30.06M
Pretax Income
$ -88.35M$ -188.92M$ -142.18M$ -72.75M$ -43.84M
Net Income
$ -95.50M$ -188.92M$ -132.18M$ -70.44M$ -40.51M
Per Share Metrics
Basic EPS
$ -1.02$ -2.37$ -2.02$ -1.14$ -0.65
Diluted EPS
$ -1.02$ -2.37$ -2.02$ -1.14$ -0.65
Weighted Average Shares Outstanding
93.62M 79.77M 65.47M 61.95M 61.93M
Weighted Average Shares Outstanding (Diluted)
93.62M 79.77M 65.47M 61.95M 61.93M
Currency in USD

Day One Biopharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis